You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
歐普康視(300595.SZ):子公司擬2404.29萬元投資萊州同明醫院 將持有其51%股權
格隆匯 08-25 18:11

格隆匯 8 月 25日丨歐普康視(300595.SZ)公佈,2020年8月25日,公司全資子公司歐普康視投資有限公司(“歐普投資”、“甲方”)與史建俊(“丙方1”)、蔣翠蘭(“丙方2”)、餘有德(“丙方3”)在安徽省合肥市簽訂了《歐普康視投資有限公司與史建俊、蔣翠蘭、餘有德關於萊州同明中西醫結合醫院有限公司之投資合作協議》,歐普投資擬以自有資金人民幣2404.29萬元以受讓股權及增資擴股的方式投資於萊州同明中西醫結合醫院有限公司(“萊州同明醫院”、“乙方”、“標的公司”)。此次投資完成後,歐普投資將持有乙方51%的股權。

標的公司萊州同明醫院位於山東省萊州市,業務以眼科診療與手術、視光產品與服務為主,兼具中醫科、檢驗科等,其擁有良好的檢驗設備和就診環境,具備較為專業的經營團隊與專家資源,可為患者提供精確化的診療服務,自開業以來業務規模上升、盈利能力趨好,在當地具有較好的口碑和一定的影響力。

此次投資合作一方面有利於拓展公司在萊州地區的業務佈局,提升公司的市場份額,增強公司的盈利能力,增加公司的業績;另一方面,公司將藉此契機,加強區域資源整合,擴大公司在當地的行業影響力。此次投資對上市公司未來財務狀況和經營成果具有積極的影響,符合公司的長遠發展戰略和全體股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account